Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis.

IF 5 2区 医学 Q1 CLINICAL NEUROLOGY Multiple Sclerosis Journal Pub Date : 2025-04-01 DOI:10.1177/13524585251329035
Daniel Merlo, Johnson Ja, Yi Chao Foong, Chao Zhu, Melissa Gresle, Tomas Kalincik, Jeannette Lechner-Scott, Trevor Kilpatrick, Michael Barnett, Bruce Taylor, Katherine Buzzard, David Darby, Helmut Butzkueven, Anneke van der Walt
{"title":"Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis.","authors":"Daniel Merlo, Johnson Ja, Yi Chao Foong, Chao Zhu, Melissa Gresle, Tomas Kalincik, Jeannette Lechner-Scott, Trevor Kilpatrick, Michael Barnett, Bruce Taylor, Katherine Buzzard, David Darby, Helmut Butzkueven, Anneke van der Walt","doi":"10.1177/13524585251329035","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Monitoring of cognition in multiple sclerosis (MS) is critical. Traditional cognitive testing is resource intensive and insensitive to subtle changes. Digital tests could address this need; however, their long-term usability remains unexplored.</p><p><strong>Objectives: </strong>To determine the long-term acceptability and feasibility of digital cognitive measures in MS.</p><p><strong>Methods: </strong>Participants with relapsing or secondary progressive MS were prospectively enrolled. MSReactor, a web-based test evaluating processing speed, attention and working memory, was performed 6-monthly for up to 36 months. Patient acceptability, anxiety, depression and quality of life were collected concurrently. Correlations between test acceptability, psychosocial measures, physical disability and cognition were analysed using Spearman's correlation.</p><p><strong>Results: </strong>This study included participants with complete data at 12 (<i>n</i> = 601), 24 (<i>n</i> = 280) and 36 (<i>n</i> = 317) months. Attrition after 12 months was low (3.5%). Acceptability of MSReactor was high, although interest and enjoyment decreased slightly. Minor correlations were observed between reduced acceptability and increased anxiety, depression and disability and lower quality of life.</p><p><strong>Conclusion: </strong>Long-term cognitive monitoring was highly acceptable. We identified characteristics, such as increased anxiety, that were associated with reduced acceptability. Patients with these characteristics may benefit from support to maintain monitoring. These findings underscore the potential for integrating such tools into MS care.</p>","PeriodicalId":18874,"journal":{"name":"Multiple Sclerosis Journal","volume":" ","pages":"595-606"},"PeriodicalIF":5.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12008470/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13524585251329035","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Monitoring of cognition in multiple sclerosis (MS) is critical. Traditional cognitive testing is resource intensive and insensitive to subtle changes. Digital tests could address this need; however, their long-term usability remains unexplored.

Objectives: To determine the long-term acceptability and feasibility of digital cognitive measures in MS.

Methods: Participants with relapsing or secondary progressive MS were prospectively enrolled. MSReactor, a web-based test evaluating processing speed, attention and working memory, was performed 6-monthly for up to 36 months. Patient acceptability, anxiety, depression and quality of life were collected concurrently. Correlations between test acceptability, psychosocial measures, physical disability and cognition were analysed using Spearman's correlation.

Results: This study included participants with complete data at 12 (n = 601), 24 (n = 280) and 36 (n = 317) months. Attrition after 12 months was low (3.5%). Acceptability of MSReactor was high, although interest and enjoyment decreased slightly. Minor correlations were observed between reduced acceptability and increased anxiety, depression and disability and lower quality of life.

Conclusion: Long-term cognitive monitoring was highly acceptable. We identified characteristics, such as increased anxiety, that were associated with reduced acceptability. Patients with these characteristics may benefit from support to maintain monitoring. These findings underscore the potential for integrating such tools into MS care.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
MSReactor数字认知监测在多发性硬化症患者中的长期可接受性
背景:监测多发性硬化症(MS)的认知是至关重要的。传统的认知测试是资源密集型的,对细微的变化不敏感。数字测试可以满足这一需求;然而,它们的长期可用性仍有待探索。目的:确定数字认知测量在多发性硬化症中的长期可接受性和可行性。方法:前瞻性纳入复发性或继发性进展性多发性硬化症患者。MSReactor是一项基于网络的测试,评估处理速度、注意力和工作记忆,每6个月进行一次,最长可达36个月。同时收集患者的可接受性、焦虑、抑郁和生活质量。采用Spearman相关分析测试可接受性、心理社会测量、身体残疾和认知之间的相关性。结果:本研究纳入了12个月(n = 601)、24个月(n = 280)和36个月(n = 317)完整数据的参与者。12个月后的流失率很低(3.5%)。MSReactor的可接受性高,但兴趣和享受略有下降。可接受性降低与焦虑、抑郁、残疾和生活质量降低之间存在轻微的相关性。结论:长期认知监测可接受程度高。我们发现了一些特征,比如焦虑增加,这些特征与接受度降低有关。具有这些特征的患者可能受益于支持维持监测。这些发现强调了将这些工具整合到MS护理中的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Multiple Sclerosis Journal
Multiple Sclerosis Journal 医学-临床神经学
CiteScore
10.90
自引率
6.90%
发文量
186
审稿时长
3-8 weeks
期刊介绍: Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. The journal for your research in the following areas: * __Biologic basis:__ pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics * __Epidemology and genetics:__ genetics epigenetics, epidemiology * __Clinical and Neuroimaging:__ clinical neurology, biomarkers, neuroimaging and clinical outcome measures * __Therapeutics and rehabilitation:__ therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management Print ISSN: 1352-4585
期刊最新文献
Baló's concentric sclerosis successfully treated with alemtuzumab: Long-term follow-up. A first report of progressive multifocal leukoencephalopathy in childhood-onset NMOSD. Treating Balo's concentric sclerosis in the monoclonal antibody era. Navigating the uncharted-Progressive multifocal leukoencephalopathy in a child with NMOSD treated with rituximab. Acute retinal necrosis associated with dimethyl fumarate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1